These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 8923815)
1. A novel inhibitor of platelet aggregation from the Cyanophyceae Oscillatoria rosea (NIES-208). Rho MC; Matsunaga K; Yasuda K; Ohizumi Y Planta Med; 1996 Oct; 62(5):473-4. PubMed ID: 8923815 [TBL] [Abstract][Full Text] [Related]
2. A novel monogalactosylacylglycerol with inhibitory effect on platelet aggregation from the cyanophyceae Oscillatoria rosea. Rho MC; Matsunaga K; Yasuda K; Ohizumi Y J Nat Prod; 1996 Mar; 59(3):308-9. PubMed ID: 8882435 [TBL] [Abstract][Full Text] [Related]
3. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle. Shaw LA; Batey AJ; Coker SJ Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543 [TBL] [Abstract][Full Text] [Related]
4. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]
5. N-ethylmaleimide inhibits platelet aggregation and potentiates hydrogen peroxide formation induced by thrombin. Leoncini G Biochem Mol Biol Int; 1994 Aug; 34(1):119-26. PubMed ID: 7849614 [TBL] [Abstract][Full Text] [Related]
6. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism. Lévy-Toledano S; Grelac F; Caen JP; Maclouf J Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416 [TBL] [Abstract][Full Text] [Related]
7. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331 [TBL] [Abstract][Full Text] [Related]
8. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588 [TBL] [Abstract][Full Text] [Related]
9. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481 [TBL] [Abstract][Full Text] [Related]
11. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF. Kawikova I; Arakawa H; Skoogh BE; Löfdahl CG; Lötvall J J Pharmacol Exp Ther; 1996 Jul; 278(1):268-76. PubMed ID: 8764360 [TBL] [Abstract][Full Text] [Related]
12. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. Lockhart LK; McNicol A J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645 [TBL] [Abstract][Full Text] [Related]
13. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Zhou Q; Dangelmaier C; Smith JB Biochem Biophys Res Commun; 1996 Feb; 219(3):720-6. PubMed ID: 8645248 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets. Pulcinelli FM; Daniel JL; Riondino S; Gazzaniga PP; Salganicoff L Thromb Haemost; 1995 Feb; 73(2):304-8. PubMed ID: 7792747 [TBL] [Abstract][Full Text] [Related]
15. Platelet activation induced by a stable analogue of endoperoxides (U46619). Zatta A; Prosdocimi M Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389 [No Abstract] [Full Text] [Related]
16. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation. Heinroth I; Block HU; Mest HJ Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555 [TBL] [Abstract][Full Text] [Related]
17. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation. Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets. Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213 [TBL] [Abstract][Full Text] [Related]
19. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor. Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557 [No Abstract] [Full Text] [Related]
20. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood. Sanderson HM; Heptinstall S; Vickers J; Lösche W Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]